C4 Therapeutics to Present at the Jefferies Virtual London Healthcare Conference

Rhea-AI Summary

C4 Therapeutics (Nasdaq: CCCC), a biopharmaceutical innovator, will present at the Jefferies Virtual London Healthcare Conference on November 19, 2020, at 8:30 a.m. ET. C4T specializes in a unique class of small-molecule drugs aimed at selectively degrading disease-causing proteins, targeting conditions like cancer and neurodegenerative diseases. A live webcast of the presentation will be available on their website, with a replay archived for two weeks. This targeted protein degradation approach offers potential advantages over traditional therapies, including reduced drug resistance and fewer side effects.

WATERTOWN, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule drugs that selectively destroys disease-causing proteins through degradation, today announced that the Company will present at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 8:30 a.m. ET.

A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.c4therapeutics.com. A replay of the webcast will be archived on the C4T website for at least two weeks following the presentation.

About C4 Therapeutics
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity. To learn more about C4 Therapeutics, visit www.C4Therapeutics.com.

FAQ

When is C4 Therapeutics presenting at the Jefferies Virtual London Healthcare Conference?

C4 Therapeutics will present on November 19, 2020, at 8:30 a.m. ET.

How can I watch the C4 Therapeutics presentation?

The presentation can be watched via a live webcast on the C4 Therapeutics website under the 'Events & Presentations' section.

What is the focus of C4 Therapeutics?

C4 Therapeutics focuses on developing small-molecule drugs that target and degrade disease-causing proteins.

What advantages does C4 Therapeutics’ approach offer?

Their approach offers potential benefits like reduced drug resistance, higher potency, and decreased side effects compared to traditional therapies.

Is there a replay available for the C4 Therapeutics presentation?

Yes, a replay of the presentation will be archived on the C4 Therapeutics website for at least two weeks after the event.